PD-L1 expression-related PI3K pathway correlates with immunotherapy efficacy in gastric cancer

BACKGROUND: The programed death ligand-1 combined positive score (PD-L1 CPS), the only FDA-approved biomarker for immune checkpoint inhibitor therapy in gastric cancer (GC) patients, is an important but imperfect predictive biomarker. The molecular characteristics of tumors that influence the PD-L1...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Langbiao, Niu, Lei, Zheng, Xue, Xiao, Fei, Sun, Huaibo, Deng, Wei, Cai, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586003/
https://www.ncbi.nlm.nih.gov/pubmed/37868079
http://dx.doi.org/10.1177/17588359231205853

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10586003/
https://www.ncbi.nlm.nih.gov/pubmed/37868079
http://dx.doi.org/10.1177/17588359231205853

Ejemplares similares